The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124944352 12494435 2 F 20160513 20160630 20160623 20160708 PER US-JAZZ-2016-US-011235 JAZZ 59.75 YR M Y 0.00000 20160708 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124944352 12494435 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
124944352 12494435 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS U 21196 ORAL SOLUTION
124944352 12494435 3 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID U 21196 4.5 G ORAL SOLUTION
124944352 12494435 4 SS XYREM SODIUM OXYBATE 1 Oral 4.5 G, BID U 21196 4.5 G ORAL SOLUTION
124944352 12494435 5 SS XYREM SODIUM OXYBATE 1 UNK U 21196 ORAL SOLUTION
124944352 12494435 6 C LISINOPRIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELISINOPRIL 1 UNK U 0 TABLET
124944352 12494435 7 C MOBIC MELOXICAM 1 UNK U 0 TABLET
124944352 12494435 8 C Aspirin e.c ASPIRIN 1 UNK U 0 TABLET
124944352 12494435 9 C Atorvastatin ATORVASTATIN 1 UNK U 0 TABLET
124944352 12494435 10 C MINOXIDIL. MINOXIDIL 1 UNK U 0 TABLET
124944352 12494435 11 C EPIPEN EPINEPHRINE 1 UNK U 0
124944352 12494435 12 C Fluoxetine hcl FLUOXETINE HYDROCHLORIDE 1 UNK U 0 CAPSULE
124944352 12494435 13 C NUVIGIL ARMODAFINIL 1 UNK U 0 TABLET
124944352 12494435 14 C LORATADINE. LORATADINE 1 UNK U 0 TABLET
124944352 12494435 15 C NASONEX MOMETASONE FUROATE 1 UNK U 0 NASAL SPRAY

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124944352 12494435 1 Narcolepsy
124944352 12494435 2 Cataplexy
124944352 12494435 6 Product used for unknown indication
124944352 12494435 7 Product used for unknown indication
124944352 12494435 8 Product used for unknown indication
124944352 12494435 9 Product used for unknown indication
124944352 12494435 10 Product used for unknown indication
124944352 12494435 11 Product used for unknown indication
124944352 12494435 12 Product used for unknown indication
124944352 12494435 13 Product used for unknown indication
124944352 12494435 14 Product used for unknown indication
124944352 12494435 15 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
124944352 12494435 Hand fracture
124944352 12494435 Unevaluable event

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124944352 12494435 1 201212 2012 0
124944352 12494435 2 201212 201402 0
124944352 12494435 3 201402 0
124944352 12494435 6 20160118 0
124944352 12494435 7 20160118 0
124944352 12494435 8 20150715 0
124944352 12494435 9 20150715 0
124944352 12494435 10 20150715 0
124944352 12494435 11 20121101 0
124944352 12494435 12 20121101 0
124944352 12494435 13 20121101 0
124944352 12494435 14 20120801 0
124944352 12494435 15 20120801 0